Table 2
Clinical indicators, targets, maximum thresholds, and points for achieving targets that will probably indirectly affect chemical pathology laboratories
| Annex A code | Clinical indicator and target | Maximum threshold | Points |
|---|---|---|---|
| ACE, angiotensin converting enzyme; CHD, coronary heart disease. | |||
| CHD 11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor | 70% | 7 |
| LVD 3 | The percentage of patients with a diagnosis of CHD and left ventricular dysfunction who are currently treated with ACE inhibitors (or A2 antagonists) | 70% | 10 |
| BP 1 | The practice can produce a register of patients with established hypertension | 9 | |
| DM 15 | The percentage of patients with diabetes with proteinuria or microalbuminuria who are treated with ACE inhibitors (or A2 antagonists) | 70% | 3 |
| Epilepsy 3 | The percentage of patients aged 16 and over on drug treatment for epilepsy who have a record of medication review in the previous 15 months | 90% | 4 |
